Multidrug-resistant tuberculosis: Prevention is better than cure

Medical Journal of Australia

Volumn 164, Issue 2, 1996, Pages 121-124

  Gilbert, Gwendolyn L ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CIPROFLOXACIN; CLARITHROMYCIN; ISONIAZID; OFLOXACIN; PYRAZINAMIDE; RIFAMPICIN; RIFAMYCIN; TUBERCULOSTATIC AGENT;

CHEMOPROPHYLAXIS; HEALTH CARE PERSONNEL; HUMAN; LABORATORY DIAGNOSIS; MOLECULAR BIOLOGY; MULTIDRUG RESISTANCE; PATIENT COMPLIANCE; SHORT SURVEY; TUBERCULOSIS; TUBERCULOSIS CONTROL;

EID: 0030053519     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.1996.tb101371.x     Document Type: Short Survey

References (42)

1. Kochi A The global tuberculosis situation and the new control strategy of the World Health Organization Tubercle 1991, 72 106
2. Reider HL Cauthen GM, Kelly GD, et al Tuberculosis in the United States JAMA 1989, 262 385-389
3. Centers for Disease Control National action plan to combat multi-drug resistant tuberculosis MMWR Morb Mortal Wkly Rep 1992, 4(RR-11) 1-67
4. Bloom BR Murray CJL Tuberculosis commentary on a reemergent killer Science 1992, 257 1055-1064
5. Brudney K, Dobkin J Resurgent tuberculosis in New York City, human immunodeficiency virus, homelessness and the decline of tuberculosis control programs Am Rev Respir Dis 1991, 144: 745-749
6. Hargreaves J Tuberculosis notifications in Australia 1993 Commun Dis Intell 1995, 19 334-343
7. Iseman MD Treatment of multi-drug-resistant tuberculosis N Engl J Med 1993; 329 784-791
8. Freiden TR Sterling T, Pablos-Mendez A, et al. The emergence of drug-resistant tuberculosis in New York City N Engl J Med 1993, 328 521-526
9. Curran M, Dawson D Tuberculosis in Australia bacteriological confirmed cases and drug resistance. 1993 Commun Dis Intell 1995. 19 343-345
10. Musser JM Antimicrobial agent resistance in mycobacteria molecular genetic insights Clin Microbiol Rev 1995, 8 496-514
11. Mahmoudi A, Iseman MD Pitfalls in the care of patients with tuberculosis Common errors and their association with the acquisition of drug resistance JAMA 1993; 270: 65-68
12. Centers for Disease Control Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons - Florida and New York 1988-1991 MMWR Morb Mortal Wkly Rep 1991; 40 585-591
13. Centers for Disease Control, Probability of transmission of multidrug resistant tuberculosis in a correctional facility - California MMWR Morb Mortal Wkly Rep 1993. 42 48-51
14. Edlin BR, Tokars JI Grieco MH, et al An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome N Engl J Med 1992, 326 1514-1521
15. Pearson ML, Jereb JA, Frieden TR, et al Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis A risk to patients and health care workers Ann Intern Med 1992, 117 191-196
16. Beck-Sangue C, Dooley SW, Hutton MD, et al Hospital outbreak of multidrug-resistant Mycobacterium tuberculosis infections. Factors in transmission to staff and HIV-infected patients JAMA 1992, 268 1280-1286
17. Chawla PK, Klapper PJ Kamholz SL, et al Drug-resistant tuberculosis in an urban population including patients at risk for human immunodeficiency virus infection Am Rev Respir Dis 1992, 146 280-284.
18. Fischl MA, Daikos GL, Uttamchandani RB, et al Clinical presentation and outcome of patients with HIV infection and tuberculosis caused by multi-drug-resistant bacilli Ann Intern Med 1992, 117 184-190
19. Fischl MA, Uttamchandani RB, Daikos GL, et al An outbreak of tuberculosis caused by multiple-drug-resistant tubercle bacilli among patients with HIV infection Ann Intern Med 1992, 117 177-183
20. Busillo CR Lessnau K-D, Sanjana V, et al Multidrug resistant Mycobacterium tuberculosis in patients with human immunodeficiency virus infection Chest 1992, 102 797-801
21. Small PM, Shafer RW, Hopewell PC, et al Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection N Engl J Med 1993; 328 1137-1144
22. Valway S, Greifinger R Risk of HIV positive persons becoming infected and developing disease after exposure to multidrug resistant tuberculosis. 23rd Interscience Conference on Antimicrobial Agents and Chemotherapy, 1993 Oct 19-22, New Orleans Washington American Society of Microbiologists, 1993 [Abstract 607]
23. Kramer F, Modilevsky T, Waliany AR, et al Delayed diagnosis of tuberculosis in patients with human immunodeficiency virus infection Am J Med 1990, 89 451-456.
24. Centers for Disease Control Management of persons exposed to multidrug resistant tuberculosis MMWR Morb Mortal Wkly Rep 1992, 41(RR-11) 61-71
25. Goble M Iseman MD Madsen LA, et al Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampicin N Engl J Med 1993, 328 527-532
26. Horn DL, Hewlett D, Alfalla C, et al Limited tolerance of ofloxacin and pyrazinamide prophylaxis following exposure to rifampicin-, isoniazid-, streptomycin- and ethambutol-resistant tuberculosis 23rd Interscience Conference on Antimicrobial Agents and Chemotherapy, 1993 Oct 19-22, New Orleans Washington American Society of Microbiologists, 1993 [Abstract 609]
27. Iseman MD, Madsen L, Goble M, Pomerantz M Surgical intervention in the treatment of pulmonary disease caused by drug-resistant Mycobacterium tuberculosis Am Rev Respir Dis 1990, 141 623-625
28. Cohn DL, Catlin BJ, Peterson KL, et al A 62-dose 6-month therapy for pulmonary and extrapulmonary tuberculosis a twice-weekly, directly observed and cost-effective regimen Ann Intern Med 1990, 112 407-415
29. Controlling Tuberculosis in New South Wales Sydney, New South Wales Health Department, 1993
30. Iseman MD, Cohn DL, Sbarbaro JA Directly observed treatment of tuberculosis We can't afford not to try it N Engl J Med 1993, 328 576-578.
31. Vlaspolder F Singer P, Roggeveen C Diagnostic value of an amplification method (Gen-Probe) compared with that of culture for diagnosis of tuberculosis J Clin Microbiol 1995, 33 2699-2703
32. Moore DF, Curry JI Detection and identification of Mycobacterium tuberculosis directly from sputum sediments by Amplicor PCR J Clin Microbiol 1995, 33 2686-2691
33. Jacobs WR, Barletta RG, Udani R, et al Rapid assessment of drug susceptibilities of Mycobacterium tuberculosis by means of luciferase reporter phages. Science 1993 260 819-822
34. Telenti A, Imboden P, Marchesi F et al Direct, automated detection of rifampm-resistant Mycobacterium tuberculosis by polymerase chain reaction and single-strand conformation polymorphism analysis Antimicrob Agents Chemother 1993, 2054-2058
35. Zhang Y, Heym B Allen B, et al The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis Nature 1992, 358: 591-593
36. Centers for Disease Control Guidelines for preventing the transmission of tuberculosis in health-care settings, with special focus on HIV-related issues MMWR Morb Mortal Wkly Rep 1990, 39 (RR-17) 1-29
37. Iseman MD A leap of faith What can we do to curtail intrainstitutional transmission of tuberculosis? Ann Intern Med 1992, 117 251-253
38. Catanzaro A Preventing nosocomial transmission of tuberculosis Lancet 1995. 345 204-205.
39. Segal-Maurer S, Kalkut GE Environmental control of tuberculosis continuing controversy Clin Infect Dis 1994, 19 299-308
40. Sepkowitz KA. AIDS, tuberculosis and the health care worker Clin Infect Dis 1995 20 232-242
41. Colditz GA, Brewer TF, Berkey CS, et al Efficacy of BCG vaccine in the prevention ot tuberculosis meta-analysis of the published literature JAMA 1994, 271 698-702
42. Greenberg PD, Lax KG, Schechter CB Tuberculosis in house staff A decision analysis comparing the tuberculin screening strategy and the BCG vaccination Am Rev Respir Dis 1991, 143 490-495